You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

172 Results
Document
May 2019
Guidelines and Advice
Status: Archived
ID: 6-23 (CED)
Jan 2012
Guidelines and Advice
Status: Current
ID: GL-C50-13
Feb 2014
Guidelines and Advice
Status: Archived
ID: 11-1
Version: 2
Oct 2014
We’ve compiled the answers to many commonly asked questions about cancer drug costs and funding in Ontario.
Drug
Quick Link(s):
Patient Info Sheet
Jan 2018
Drug
Other Name(s): Imfinzi®
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2025
Guidelines and Advice
Status: Archived
ID: 2-14
Version: 3
Apr 2011
Guidelines and Advice
Status: In-Review
ID: GL 2-24
May 2019
Drug
Other Name(s): Xgeva®; Wyost™; Osenvelt™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Dec 2025
Symptom Management
Symptom Management

Pages